Aesara has opted to establish its new European headquarters in Zug. The market access agency for biopharmaceutical companies from the US State of North Carolina is set to open its eighth branch office in Europe before the end of this month. According to a press release, Aesara will announce details regarding local leadership of the Zug location over the course of the summer.
Aesara was founded in 2016. According to information from the company itself, it is a female and minority-owned firm led by experienced biopharmaceutical industry experts from the USA, Canada and Europe.
“Carefully selected for both customer proximity and access to talent, new AESARA operations in Switzerland strengthen our global and regional presence”, explains Gavin Outteridge, General Manager for AESARA Europe, in the press release.
“Being part of the European Biopharmaceutical Cluster located in Switzerland is an important strategic step for AESARA”, comments Sissi Pham, CEO of Aesara, in the press release. According to her, this will allow the company to live out its purpose of “developing innovative and trusted solutions that power transformative market access globally”.
